首页|ASPP2重组腺病毒通过调控NF-κB信号通路抑制DEN诱导的小鼠肝细胞癌发生

ASPP2重组腺病毒通过调控NF-κB信号通路抑制DEN诱导的小鼠肝细胞癌发生

扫码查看
目的 研究ASPP2 重组腺病毒(ASPP2-ad)对二乙基亚硝胺(DEN)诱导的小鼠肝细胞癌(HCC)发生的抑制作用及其可能的作用机制.方法 采用DEN腹腔注射联合 0.005%DEN饮水方法 构建小鼠HCC模型.将动物分为DEN处理组和DEN-ASPP2-ad处理组,每组10 只.使用小动物超声成像系统动态观察小鼠HCC形成情况,大体记数肝脏肿瘤数量,采用免疫组化法检测肿瘤组织Ki67 表达,采用流式多重蛋白定量技术检测小鼠血清IL-1β、IL-6、KC、IL-2和TNFα水平,采用Western blot法检测组织AFP、caspase3、cyclinD1、PCNA、p-IKK、IKK、p-IκB、IκB、p-p65 和p65 蛋白表达,采用实时定量PCR法检测Nfatc1 mRNA水平.结果 DEN诱导24 周后,DEN组小鼠肝脏肿瘤数为(9.9±1.9)个,显著多于DEN联合ASPP2-ad组[(3.9±1.2)个,P<0.05];DEN组小鼠Ki67 阳性细胞数为(91.4±9.1)个,显著多于DEN联合ASPP2-ad组[(56.6±10.5)个,P<0.05];在实验40 周末,DEN组小鼠生存率为65.2%,显著低于DEN联合ASPP2-ad组的90.0%(P<0.05);DEN组小鼠血清ALT和AST水平分别为(271.5±143.8)U/L和(299.3±221.4)U/L,均显著高于DEN-ASPP2-ad干预组[分别为(101.7±44.6)U/L和(124.1±75.0)U/L,P<0.05];DEN联合ASPP2-ad组血清IL-6 和TNFα水平分别为(8.1±1.6)MFI和(8.1±1.0)MFI,均显著低于DEN组[分别为(16.3±0.4)MFI和(26.3±5.3)MFI,P<0.05];DEN/ASPP2-ad处理组AFP、Cyclin D1 和PCNA表达减弱,而caspase-3 表达增强,NF-κB信号通路蛋白(p-IKK、p-IκB和p-p65)表达减弱,p-IKK/IKKα、p-IκB/IκB和p-p65/p65 比值也降低,NF-κB下游癌基因Nfatc1 表达减弱(P<0.05).结论 ASPP2-ad可能通过调控NF-κB通路显著抑制DEN诱导的炎性增殖反应,阻抑HCC的发生,值得深入研究.
ASPP2 recombinant adenovirus inhibits DEN-induced hepatocarcinogenesis in mice by regulating NF-κB signaling pathway
Objective The aim of this experiment was to investigate the inhibitory effect of apoptosis stimulating protein 2 of P53(ASPP2)recombinant adenovirus(ASPP2-ad)on hepatocellular carcinogenesis induced by diethylnitrosamine(DEN)in mice.Methods The mouse liver cancer model was established by intraperitoneal injection of DEN at dose of 25 mg·kg-1 and drinking water with 0.005%of DEN.The experiment was divided into two groups with 10 mice in each group,receiving DEN or DEN and ASPP2-ad combination intervention.The formation of liver cancer in mice was observed by ultrasonography.The number of liver tumors was recorded,and the expression of Ki67 was detected by immunohistochemistry.Serum IL-1β,IL-6,KC,IL-2 and TNFα levels were detected by flow multiprotein quantification technology.The protein expressions of AFP,caspase3,cyclin D1,PCNA,p-IKK,IKK,p-IκB,IκB,p-p65 and p65 were observed by Western blot,and the Nfatc1 mRNA level was assayed by real-time quantitative PCR.Results After 24 weeks of DEN induction,the number of liver tumors in DEN-intervened group was(9.9±1.9),significantly greater than[(3.9±1.2),P<0.05]in the DEN and ASPP2-ad combination intervened group;the number of Ki67 positive cells in DEN-intervened group was(91.4±9.1),significantly greater than[(56.6±10.5),P<0.05]in DEN/ASPP2-ad-intervened group;the survival rate in the DEN-intervened group was 65.2%,significantly lower than 90.0%(P<0.05)in DEN/ASPP2-ad-intervend group(P<0.05);serum ALT and AST levels were(271.5±143.8)U/L and(299.3±221.4)U/L,both significantly higher than[(101.7±44.6)U/L and(124.1±75.0)U/L,P<0.05]in DEN/ASPP2-ad-intervend group;serum IL-6 and TNFα levels in DEN/ASPP2-ad-intervend group were(8.1±1.6)MFI and(8.1±1.0)MFI,both much lower than[(16.3±0.4)MFI and(26.3±5.3)MFI,P<0.05]in DEN-intervened group;the cancerous AFP,Cyclin D1 and PCNA expression became weaker,the p-IKK,p-IκB and p-p65 expression down-regulated,the p-IKK/IKKα,p-IκB/IκB and p-p65/p65 ratio down-regulated,the Nfatc1 expression weaker,while the caspase-3 expression intensified(P<0.05)in DEN/ASPP2-ad-intervend group.Conclusion The ASPP2-ad could remarkably inhibit DEN-induced inflammatory proliferation reaction and the occurrence of liver cancer,which might be related to the regulation of NF-κB signal pathway,and warrants further investigation.

Hepatomap53 apoptosis-stimulating protein 2DiethylnitrosamineNuclear factor κBMice

高明慧、柴梦音、寇卜心、豆双双、刘晓霓

展开 >

北京市 首都医科大学附属北京佑安医院北京肝病研究所

肝细胞癌 P53凋亡刺激蛋白2 二乙基亚硝胺 核因子κB 小鼠

北京市自然科学基金首都卫生发展科研专项基金资助项目北京市公共医学研究所发展改革试点研究项目

71920842020-2-1152京医研2021-10

2024

实用肝脏病杂志
中华医学会安徽分会

实用肝脏病杂志

CSTPCD
影响因子:1.362
ISSN:1672-5069
年,卷(期):2024.27(2)
  • 20